Shares in pharmaceuticals giant Merck (MRK) weakened today on fears that a patent battle could jeopardize its plans to sell a new version of its crucial cancer drug Keytruda. Enzyme Dispute ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other most undervalued high quality stocks to buy according to analysts. Is a Market Rally Around ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

* EPS estimates are Normalized unless otherwise noted.

After hours: 7:54:00 p.m. EST Loading Chart for MRK ...

Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...